Companies: 10,795·Total market cap: $144.5T
Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited

PBIGFOTCHealthcare● Active
$0.11
$-0.05(-30.00%)
Market Cap$45505675
P/E Ratio
52W High$0.3468
52W Low$0.10086
Overview

Paradigm Biopharmaceuticals Limited(PBIGF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PBIGF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.14pbigf eps ttm · pbigf earnings per shareEarnings history
PE Ratio (TTM)pbigf pe ratio ttm · pbigf price to earningsPE Ratio deep dive
Revenue (TTM)143059.00pbigf revenue ttm · pbigf annual revenueFull revenue history
Dividend Yield不分红does pbigf pay dividends · pbigf dividend yieldDividend history
Shares Outstanding314.5Mpbigf shares outstanding · pbigf floatShares outstanding history
Next EarningsAug 21, 2026Est.pbigf earnings date · pbigf next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$52120.00▼ 20.79% YoY
202320242025
paradigm biopharmaceuticals limited revenue · pbigf revenue 2025
FY 2025Net Income-$18.8M▲ +68.00% YoY
202320242025
paradigm biopharmaceuticals limited net income · pbigf profit 2025
FY 2025EPS$-0.06▲ +70.15% YoY
202320242025
pbigf eps · paradigm biopharmaceuticals limited earnings per share 2025
TTM:Revenue: $143059.00Net Income: -$51.7MEPS: $-0.14View income statement →

股票表现

完整历史
1D-30.00%
1W-4.55%
1M-26.24%
3M-43.10%
YTD-54.76%
1Y-59.13%
5Y-93.79%

关于 Paradigm Biopharmaceuticals Limited

CEOPaul John Rennie
IPO DateMay 10, 2019
Employees
CountryAU

Paradigm Biopharmaceuticals Limited Melbourne, Australia-based Paradigm Biopharmaceuticals Limited operates as a drug repurposing company, focusing on the discovery and development of therapeutic products for human application. The comp…

what is paradigm biopharmaceuticals limited · pbigf stock overview · paradigm biopharmaceuticals limited company profile · who is paradigm biopharmaceuticals limited ceo · pbigf OTC · paradigm biopharmaceuticals limited headquarters · paradigm biopharmaceuticals limited business segments

关于股票概览与关键数据

Paradigm Biopharmaceuticals Limited(PBIGF)是 Biotechnology 行业的 Healthcare 类公司,于 May 10, 2019 在 OTC 上市。截至最近交易日,PBIGF 股价为 $0.10,市值约为 $45.5M。过去12个月累计回报 -59.13%,年初至今回报 -54.76%。

2025 财年 Paradigm Biopharmaceuticals Limited 营收 $52120.00。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Paradigm Biopharmaceuticals Limited(PBIGF)股价为 $0.10,在 OTC 上市,52周区间为 $0.10 – $0.35。

PBIGF 最新股价PBIGF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议